Measurement of BCR-ABL1 by RT-qPCR in Chronic Myeloid Leukaemia: Findings From an International EQA Programme

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14557
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Clinical and Prognostic Significance of E1a2 BCR-ABL1 Transcript Subtype in Chronic Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2017English

Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2017English

The Benefit of Quality Control Charts (QCC) for Routine Quantitative BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

PLoS ONE
Multidisciplinary
2018English

Role of NOX2 for Leukaemic Expansion in a Murine Model of BCR-ABL1 + Leukaemia

British Journal of Haematology
Hematology
2017English

E19a2 BCR-ABL Fusion Transcript in Typical Chronic Myeloid Leukaemia: A Report of Two Cases

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal

British Journal of Haematology
Hematology
2017English

Genomic BCR-ABL1 Breakpoint Characterization by a Multi-Strategy Approach for �personalized Monitoring� of Residual Disease in Chronic Myeloid Leukemia Patients

Oncotarget
Oncology
2018English

BCR-ABL1 and Beyond

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy